Oak BioSciences

Oak BioSciences is a private U.S.-based life science services company focused on antibody engineering, custom assay development, and genome engineering for research and pharmaceutical customers. The company appears to operate primarily as a contract research and molecular biology services provider rather than as a therapeutic drug developer. Reported offerings include custom antibody design and production, antibody library construction, isotype switching, aptamer development, CRISPR construct design, genome editing, cell line development, B-cell epitope mapping, and affinity maturation. Oak BioSciences is headquartered in Sunnyvale, California and was founded in 2013 by Yiping Li. Available public information indicates it is a small, privately held, active company serving the broader life science and biotech market.